Earth Essences.Com

'Why we left!' Britons FURIOUS as Switzerland bans UK vaccine and EU nations erupt

Switzerland's drugs regulator Swissmedic today announced it had delayed approval of the AstraZeneca jab. It comes as a number of European countries have advised against use of the vaccine in older people.

Meanwhile, the EU has been at the centre of an extraordinary row with AstraZeneca - which worked with Oxford University on its jab - over supply shortages.

Express.co.uk readers hit out amid the vaccine backlash.

Commenting on this website, one said: "You couldn't make this up! Some very serious questions to ask themselves in Europe."

Another blasted: "UK envy of world medicine. EU basically extremely incompetent and jealous!!!"

A third commented: "At least we should be able to have our population fully vaccinated by the time the clowns in the EU wake up."

Another wrote: "They are entitled to their viewpoint, I will trust our scientists.

"We are used to working independently, that is why we left the EU and its constraints."

A fifth simply said: "All the more for us then."

One more added: "So why then is the EU almost declaring war on UK accusing UK of stealing supplies.

"Clearly now any consideration we were giving to donate some to the EU is pointless as they will not be using it on the most vulnerable anyway.

"No point in wasting it on them they will just have to wait for the jab they hate so much they are desperate to fight us for. Bizzare really."

Switzerland is waiting for more data on safety, efficacy and quality before giving the AstraZeneca jab the green light.

Swissmedic said in a statement: "As soon as the results have been received, a temporary authorisation according to the rolling procedure could be issued at very short notice.

"The data currently available do not point to a positive decision regarding benefits and risks."

AstraZeneca's jab has already been approved in around 50 countries including the UK.

And the EU's drugs regulator last week approved the use of the vaccine for all adults.

A new study by the University of Oxford found the jab offers protection of 76 percent up to 12 weeks after a single dose and may reduce transmission by 67 percent.

However, some European countries are restricting it to certain age groups, citing a lack of data in older people.

France, Belgium and Germany are among EU countries to recommend the jab is only given to under 65s.

It comes as the UK is pushing ahead with its vaccine rollout. The number of people who have received their first jab has passed 10 million.

The EU has come under heavy criticism over its slow rollout of jabs.

Daily Express: Katie Harris  04/02/2021